NERM
BHC icon

New England Research & Management’s Bausch Health BHC Stock Holding History

New England Research & Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,600
Closed -$202K – 167
2014
Q2 		$202K Buy
+1,600
New +$204K 0.18% 149
2014
Q1 		– Sell
-2,100
Closed -$247K – 144
2013
Q4 		$247K Buy
+2,100
New +$230K 0.24% 134

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

New England Research & Management's BHC Position: Q3 2014 in Review

New England Research & Management sold out of Bausch Health (BHC) in Q3 2014, closing a stake of 1,600 shares — an estimated $202K sold.

New England Research & Management first reported a position in BHC in Q4 2013 and held it in 2 quarters. The position peaked at $247K in Q4 2013. 454 funds tracked by Wall St. Rank hold BHC as of Q3 2014.

  • New England Research & Management reported no remaining Bausch Health position as of Q3 2014 after selling out during the quarter.
  • New England Research & Management sold 1,600 Bausch Health shares in Q3 2014, an estimated $202K.
  • New England Research & Management first reported a position in Bausch Health in Q4 2013 and held it in 2 quarters.
  • New England Research & Management's Bausch Health position peaked at $247K in Q4 2013.
  • 454 funds tracked by Wall St. Rank held Bausch Health as of Q3 2014.

Based on New England Research & Management's 13F filing for Q3 2014, filed 15 Oct 2014.